Treating eye disease with gene therapy with Jasleen Jolly MCOptom

In the first episode of 2020, Martin and Daniel introduce Jasleen
Kaur Jolly MCOptom, optometrist and researcher working at the
Nuffield Laboratory of Ophthalmology and Wellcome Integrative
Neuroimaging centre, University of Oxford, and Oxford Eye
Hospital. Jasleen talks to Martin about how she got into
research, imposter syndrome, how gene therapy works, which
conditions are closer to being treated with gene therapy and what
that means for optometrists, as well as the brain and the eye.
Jasleen is involved in clinical research in the fields of retinal
gene therapy, surgery outcomes and low vision. She is currently
finishing a National Institute of Health Research funded PhD and
also won the College's highly prestigious Philip Cole Prize for
practice-based research in 2018.